The effect of Renal Denervation on Renal Flow in Humans

The effect of Renal Denervation on Renal Flow in Humans - Renal Flow after pRDN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39747

Enrollment

Registered

2013-03-05

Start date

2013-05-07

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high blood pressure intrarenal flow

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Individual is accepted for treatment with renal denervation as standard therapy for resistant hypertension. 2. Individual is >=18 years of age. 3.Individual agrees to have all study procedures performed, and is competent and willing to provide written informed consent to participate in this clinical study.

Exclusion criteria

Exclusion criteria: 1.Individual is excluded from treatment with pRDN . 2.Individual has an estimated glomerular filtration rate (eGFR) of

Design outcomes

Primary

Measure	Time frame
Primarily the effect of pRDN on renal blood flow, assessed by a change in average peak flow velocity, both in baseline as well as hyperaemic conditions.	—

Secondary

Measure	Time frame
The effect of pRDN on renal flow reserve (RFR), and hyperaemic microvascular resistance (HMR).	—

Countries

Netherlands

Outcome results